REFERENCES
- Bellen, H.J., Levis, R.W., Liao, G., He, Y., Carlson, J.W., Tsang, G., Evans-Holm, M., Hiesinger, P.R., Schulze, K.L., Rubin, G.M., Hoskins, R.A., &. Spradling, A.C. (2004). The BDGP gene disruption project: single transposon insertions associated with 40% of Drosophila genes. Genetics 167, 761–781.
- Collier, L.S., Carlson, C.M., Ravimohan, S., Dupuy, A.J., &. Largaespada, D.A. (2005). Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse. Nature 436, 272–276.
- Couzin, J. &. Kaiser, J. (2005). Gene therapy. As Gelsinger case ends, gene therapy suffers another blow. Science 307, 1028.
- Duan, D., Yue, Y., Yan, Z., &. Engelhardt, J.F. (2000). A new dual-vector approach to enhance recombinant adeno-associated virus-mediated gene expression through intermolecular cis activation. Nat. Med. 6, 595–598.
- Duffy, J.B. (2002). GAL4 system in Drosophila: a fly geneticist's Swiss army knife. Genesis 34, 1–15.
- Dupuy, A.J., Akagi, K., Largaespada, D.A., Copeland, N.G., &. Jenkins, N.A. (2005). Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system. Nature 436, 221–226.
- Ganetzky, B. &. Wu, C.F. (1982). Indirect suppression involving behavioral mutants with altered nerve excitability in Drosophila melanogaster. Genetics 100, 597–614.
- Green, C.C., Sparrow, J.C., &. Ball. E. (1986). Flight testing columns. Drosophila Inform. Serv. 63, 141.
- Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M.P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C.S., Pawliuk, R., Morillon, E., Sorensen, R., Forster, A., Fraser, P., Cohen, J.I., de Saint Basile, G., Alexander, I., Wintergerst, U., Frebourg, T., Aurias, A., Stoppa-Lyonnet, D., Romana, S., Radford-Weiss, I., Gross, F., Valensi, F., Delabesse, E., Macintyre, E., Sigaux, F., Soulier, J., Leiva, L. E., Wissler, M., Prinz, C., Rabbitts, T.H., Le Deist, F., Fischer, A., &. Cavazzana-Calvo, M. (2003). LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302, 415–419.
- Janson, C.G., McPhee, S.W., Leone, P., Freese, A., &. During, M.J. (2001). Viral-based gene transfer to the mammalian CNS for functional genomic studies. Trends Neurosci. 24, 706–712.
- Karess, R.E. &. Rubin, G.M. (1984). Analysis of P transposable element functions in Drosophila. Cell 38, 135–146.
- Palmiter, R.D. &. Brinster, R.L. (1986). Germ-line transformation of mice. Annu. Rev. Genet. 20, 465–499.
- Pirrotta, V. (1988). Vectors for P-mediated transformation in Drosophila. In (R.L. Rogregez & D.T. Dengardt (Eds.), Vectors: A Survey of Molecular Cloning Vectors and their Uses, pp. 437–456, Butterworths: Boston.
- Robertson, H.M., Preston, C.R., Phillis, R.W., Johnson-Schlitz, D.M., Benz, W.K., &. Engels, W.R. (1988). A stable genomic source of P element transposase in Drosophila melanogaster. Genetics 118, 461–470.
- Rubin, G.M. &. Spradling, A.C. (1982). Genetic transformation of Drosophila with transposable element vectors. Science 218, 348–353.
- Sinclair, J.H. (1987). The human cytomegalovirus immediate early gene promoter is a strong promoter in cultured Drosophila melanogaster cells. Nucleic Acids Res. 15, 2392.
- Suzuki, D.T., Grigliatti, T., &. Williamson, R. (1971). Temperature-sensitive mutations in Drosophila melanogaster. VII. A mutation (para-ts) causing reversible adult paralysis. Proc. Natl. Acad. Sci. USA. 68, 890–893.
- Thomas, C.E., Ehrhardt, A., &. Kay, M.A. (2003). Progress and problems with the use of viral vectors for gene therapy. Nat. Rev. Genet. 4, 346–358.
- Tower, J., Karpen, G.H., Craig, N., &. Spradling, A.C. (1993). Preferential transposition of Drosophila P-elements to nearby chromosomal sites. Genetics. 133, 347–359.
- Verma, I.M. &. Weitzman, M.D. (2005). Gene therapy: twenty-first century medicine. Annu. Rev. Biochem. 74, 711–738.
- Washbourne, P &. McAllister, A.K. (2002). Techniques for gene transfer into neurons. Curr. Opin. Neurobiol. 12, 566–573.